Q2 Earnings Forecast for Repligen Issued By Leerink Partnrs
Repligen Co. (NASDAQ:RGEN – Free Report) – Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Repligen in a note issued to investors on Thursday, April 17th. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will earn $0.42 per share for the quarter, down from their prior estimate of $0.43. […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Repligen in a note issued to investors on Thursday, April 17th. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will earn $0.42 per share for the quarter, down from their prior estimate of $0.43. […]
